Navigating 16 Analyst Ratings For Exelixis
Portfolio Pulse from Benzinga Insights
Exelixis (NASDAQ:EXEL) has received mixed analyst ratings over the past three months, with a recent positive shift in price targets. Analysts have raised their average 12-month price target by 7% to $30.25. The company shows strong financial performance with high revenue growth, net margin, ROE, and ROA, and a low debt-to-equity ratio.
October 21, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exelixis has received a mix of bullish and somewhat bullish ratings from analysts, with a recent increase in the average 12-month price target to $30.25. The company's strong financial performance, including high revenue growth and profitability, supports this positive outlook.
The majority of analysts have a bullish outlook on Exelixis, with several raising their price targets. The company's strong financial metrics, such as high revenue growth and profitability, support the positive sentiment. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100